Table 2

 Results for pelvic inflammatory disease (n = 194) and ectopic pregnancy patients (n = 83) compared to the control group

Age groupPID patients(%)EP patients(%)Pregnant(Ctrl) (%)PID vs CtrlEP vs Ctrl
Crude OR(95% CI)Adjusted OR(95% CI)Crude OR(95% CI)Adjusted OR(95% CI)
Results for pelvic inflammatory disease (PID) patients (n = 194) and ectopic pregnancy (EP) patients (n = 83) seropositive in the M genitalium LAMP-EIA and Chlamydia trachomatis IgG EIA (CT) as compared to results for the control group (Ctrl) of healthy pregnant women (three for each EP case). Statistical analyses were carried out by logistic regression. The effect parameter is expressed as the odds ratio (OR) and its 95% confidence interval (CI). Crude OR with variable age and adjusted OR with the variables age, LAMP and CT were included in the model. EP, ectopic pregnancy; PID, pelvic inflammatory disease.
*The age group for the EP patients and the control group is 18–30 years.
†The age group for the EP patients and the control group is 31–42 years.
‡One serum sample from one patients in each patient material was not found.
§Results were equivocal in the CT EIA for 7 PID patients, 5 EP patients, and 5 in the control group of pregnant women.
15–30 years*
    LAMP18 (26/143)20 (9/44)11 (15/132)1.9 (0.8 to 4.2)1.3 (0.6 to 3.0)2.0 (0.8 to 5.0)1.6 (0.6 to 4.0)
    CT54 (77/143)59 (26/44)29 (39/132)4.2 (2.2 to 7.8)4.0 (2.1 to 7.6)3.5 (1.7 to 7.1)3.3 (1.6 to 6.8)
31–50 years†
    LAMP14 (7/50)16 (6/38)18 (21/114)0.7 (0.3 to 1.8)0.6 (0.2 to 1.6)0.8 (0.3 to 2.2)0.7 (0.2 to 1.9)
    CT54 (27/50)55 (21/38)45 (51/114)1.4 (0.7 to 2.7)1.6 (0.8 to 3.2)1.5 (0.7 to 3.2)1.6 (0.8 to 3.6)
Total‡
    LAMP17 (33/193)18 (15/82)15 (36/246)1.3 (0.7 to 2.2)1.0 (0.6 to 1.7)1.3 (0.7 to 2.5)1.0 (0.5 to 2.0)
    CT54§ (104/193)57§ (47/82)37§ (90/246)2.5 (1.6 to 3.7)2.5 (1.6 to 3.8)2.4 (1.4 to 3.9)2.3 (1.4 to 4.0)